+
Site Tour

Search

  • Echo Course Webinars

    ON DEMAND Echo Course Webinars 2024 Echo guidance for screening and interventions in structural heart diseases Abbott is committed to sharing knowledge and education in structural heart. Watch…

  • Guidelines

    © Abbott 2023. All rights reserved. 9-EH-5-14472-01 08-2023 Summary of the current guidelines PMR SMR ESC/EACTS – GUIDELINES FOR THE MANAGEMENT OF VALVULAR HEART DISEASE…

  • EPIC™ Max Features

    PORCINE LEAFLETS LOW AORTIC PROTRUSION UNIQUE PERICARDIAL…

  • EPIC™ MAX Patients who benefit

    BIOPROSTHETIC AORTIC VALVE REPLACEMENT The Epic Max valve is indicated for patients requiring replacement of a diseased, damaged, or malfunctioning native aortic valve. It may also be used as a…

  • EPIC™ Plus Features

    THE PLATFORM FOR POSSIBILITY The Epic™ Platform has been proven over time and defined by strong hemodynamics, intuitive implantability, a future-forward design, and more. The platform boasts the low…

  • Patients who benefit

    SURGICAL VALVE TREATMENT FOR MITRAL AORTIC VALVE DISEASE The Epic™ Plus Mitral stented tissue valve is indicated for patients requiring replacement of a diseased, damaged, or malfunctioning native…

  • Overview

    At 10 years after implantation, this real-world nationwide study of Medicare beneficiaries receiving the Epic™ Mitral valve demonstrates: 91.4% freedom from all-cause mitral valve…

  • EPIC™ MAX Overview

    EARLY OUTCOMES AND A PERSPECTIVE ON PORCINE VS. BOVINE IN AORTIC POSITION Watch the latest expert webinar outlining how the Epic™ Max valve optimizes clinical outcomes with unparalleled*…

  • Overview

    MITRAL VALVE DISEASE Mitral Regurgitation (MR) occurs when the mitral valve leaflets fail to properly close during ventricular contraction (systole) so blood flows back into the left atrium, leading…

  • Overview

    FROM THE #1 COMPANY IN CONGENITAL OCCLUDERS1 The Amplatzer™ line not only pioneered structural heart defect occluder devices, it remains the leader in innovation and treatment worldwide. The…

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline